Crohn's Disease and Colitis Trial, Recruiting NCT06553053 Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06553053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with Crohn's disease (CD)
  • People aged between 16 and 75 years old
  • People whose Crohn's disease is currently in remission, meaning their disease activity scores, blood inflammation markers, or stool tests are within normal ranges, or no ulcers are visible on a camera examination of the gut
  • People who have had 2 or more flare-ups of their Crohn's disease in recent years
  • People who are either not currently taking medication, or are only taking one or more of the following: mesalazine (at a certain dose), prednisone (at a low dose), or azathioprine (at a certain dose) — and have been on these for a minimum period of time — or people whose bodies have stopped responding well to certain biological medicines (such as anti-TNF-α, IL-12p40, or α4β7 treatments) (confirm with trial site for specific doses and timeframes)
  • People who have never had acupuncture before
  • People who have read and signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People who are currently pregnant, recently pregnant, or breastfeeding
  • People who have serious diseases affecting major organs or body systems
  • People who have been diagnosed with a psychotic illness
  • People who have multiple health conditions requiring long-term use of other medications that could interfere with measuring how well the trial treatment works
  • People with severe skin conditions (such as painful red skin nodules or skin ulcers), serious eye conditions (such as inflammation inside the eye), blood clot disorders, or other significant complications outside the gut
  • People who have serious gut-related complications such as abnormal connections between organs (fistulas), pockets of infection in the abdomen, narrowing or blockage of the bowel, anal abscesses, gut bleeding, or a hole in the bowel wall
  • People with short bowel syndrome, or who have had abdominal or gut surgery within the past six months
  • People who have skin conditions, wounds, or other skin problems in the areas of the body where acupuncture would be performed, making acupuncture unsafe in those areas

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bao Chunhui, MD, PhD, Shanghai University of TCM

Phone: +862164395973

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The proportion of recurrences

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov